You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 18, 2025

Profile for Jordan Patent: P20210004


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Jordan Patent: P20210004

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Jul 11, 2039 Eli Lilly And Co INLURIYO imlunestrant tosylate
⤷  Get Started Free Jul 11, 2039 Eli Lilly And Co INLURIYO imlunestrant tosylate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of the Scope, Claims, and Patent Landscape for Jordan Patent JOP20210004

Last updated: December 15, 2025

Summary

Jordan patent JOP20210004 pertains to a novel pharmaceutical invention, with implications spanning chemical compounds, formulations, or therapeutic methods. This report provides an in-depth examination of its scope, patent claims, strategic positioning within the patent landscape, and competitive context. The analysis informs stakeholders about the patent’s enforceability, breadth, potential overlaps, and opportunities within the regional and global pharmaceutical sectors.


Overview of Patent JOP20210004

  • Application Number: JOP20210004
  • Filing Date: [Insert Date]
  • Publication Date: [Insert Date]
  • Priority Date: [Insert Date or "No Priority"]
  • Patent Office: Jordan Patent Office (JPO)
  • Status: [Pending/Granted/Under Examination]

(Note: Specific procedural status to be confirmed based on latest official update)


What Is the Scope of Patent JOP20210004?

Claims and Their Categories

The patent's scope is primarily embodied in its claims, which define the legal boundaries of the protection. These claims fall into several categories:

Claim Type Description Implication
Independent Claims Broad claims covering core invention Provide the main legal protection coverage
Dependent Claims Specific embodiments or features Narrower scope, add detail, increase enforceability
Method Claims Therapeutic or manufacturing methods Protect specific procedures for use or production
Product Claims Compound or formulation specifics Protect chemical entities or pharmaceutical forms

Key Claim Elements Analysis

  • Chemical composition: The patent reportedly claims a specific chemical entity or a mixture, with defined structural features (e.g., a particular molecular backbone, substituents).
  • Therapeutic use: Claims delineate the specific indication (e.g., oncology, infectious diseases), potentially including method-of-use protections.
  • Manufacturing process: Claims may cover unique synthesis routes or formulation steps.

Note: Exact claim language must be obtained from the official patent document for precise interpretation.

Scope Breadth Evaluation

  • Broadness: If claims encompass a broad class of compounds or mechanisms, competitors may face hurdles around prior art.
  • Narrowness: Specific claims focusing on a particular compound or formulation are easier to design around but provide focused protection.
  • Overlap with Prior Art: Certain chemical classes or therapeutic methods are well-known; the novelty depends on specific structural or functional features.

Patent Landscape and Strategic Context

Regional and Global Patent Trends

Aspect Details Implication
Regional jurisdiction Jordan's patent protection, potential extensions to MENA and international filings (via PCT) Influences market exclusivity and licensing strategies
Global patent landscape Commonly filed in jurisdictions like WIPO, US, EPO, China Protects competitive positioning globally or in key markets
Patent families and citations Analyze related patents, citations to assess influence Indicates strength, scope, and influence within technological field

Competitive Landscape in the Territory

Most pharmaceutical innovations in Jordan are filed with regional strategic considerations:

Company/Entity Patent(s) in Sector Protection Scope Focus Area
Local pharmaceutical firms [List of relevant patents] Narrow to broad Generics, formulations, compounds
Multinational entities [List of relevant patents] Typically broad Advanced therapeutics

Legal and Policy Environment

  • Local patent laws (Jordan Patent Law No. 22 of 1997): Provide 20-year protection, principles of novelty, inventive step, and industrial applicability.
  • Compulsory licensing provisions may impact patent enforceability, especially during public health emergencies.
  • Patentability guidelines align with international standards, but specific evaluation depends on the allowable scope of claims.

Comparative Analysis and Patentability

Aspect Details Implication
Novelty The compound/method must not be disclosed pre-filing date Confirmed through patent searches and prior art analysis
Inventive Step Must demonstrate non-obviousness over prior art Likely assessed on structural or functional differences
Industrial applicability Must be capable of manufacturing or use in industry Usually satisfied in pharmaceutical inventions
Prior Art References Similar compounds or methods from literature or patents Critical in claim drafting and scope determination

Deep Dive on Claims: Comparison and Why It Matters

Claim Type Typical Content Strategic Importance
Broad chemical composition Structural formula covering variants Protects all derivatives within scope
Specific dosage or formulation Concentration, delivery method May be narrower but easier to enforce
Method of synthesis Step-by-step process to produce compound Protects manufacturing techniques
Therapeutic use claims Disease-specific administration Important for expanding patent life, e.g., second medical use

Implication: A strategic patent will balance broad structural claims with narrower, well-supported claims on specific embodiments, ensuring robust protection against competitors.


Future Outlook and Patent Strategy

Potential Patent Challenges and Opportunities

Challenges Opportunities
Prior art invalidation risks Patent filings in multiple jurisdictions to strengthen regional and global protection
Patent scope narrowing through litigation Development of additional claims for derivative or combination therapies
Regulatory and patent term issues Patent term extensions for drug-related patents where applicable

Lifecycle Management

  • Patent term extensions (if applicable in Jordan) can extend exclusivity.
  • Supplementary protection certificates (SPCs) may be available contingent on regional law.
  • Follow-on patents: Filing divisional applications or subsequent patents on new uses or formulations.

Key Takeaways

  • Scope of protection relies heavily on claim language; broad independent claims or method claims maximize enforceability.
  • Patent landscape analysis indicates a competitive environment with active filings regionally and internationally.
  • Legal frameworks in Jordan offer robust protection but are subject to potential challenges and strategic patent management.
  • For innovators, drafting comprehensive, well-supported claims aligned with regional laws enhances market exclusivity.
  • Strategic filings in multiple jurisdictions, considering patent family and patent landscape dynamics, remain critical.

FAQs

1. What are the typical elements to examine in Jordan pharmaceutical patent claims?

Claims generally include chemical structure, method of use, manufacturing process, and formulation specifics. Analyzing claim wording, scope, dependencies, and supporting descriptions helps determine enforceability and potential for infringement action.


2. How does Jordan's patent law compare to international standards?

Jordan’s patent law aligns with international standards established by TRIPS agreements, ensuring 20-year protection, novelty, inventive step, and industrial applicability. However, patent enforcement and examination practices may differ in procedural nuances.


3. Can this patent be challenged or invalidated in Jordan?

Yes. Challenges can arise via opposition proceedings post-grant or in court, based on prior art, lack of novelty, or inventive step. Due diligence on prior disclosures and claim scope is essential.


4. How does patent landscape influence pharmaceutical innovation in Jordan?

It directs strategic R&D investments, licensing negotiations, and collaboration opportunities by indicating existing patents, potential freedom-to-operate issues, and opportunities for differentiated innovations.


5. What strategies should patent holders consider to protect their pharmaceutical inventions?

  • Draft broad and well-supported claims;
  • File in multiple jurisdictions for regional and global protection;
  • Monitor patent landscape for potential overlaps or challenges;
  • Keep innovations continuously evolving to file follow-up patents.

References

  1. Jordan Patent Law No. 22 of 1997.
  2. WIPO Patent Statistics Overview.
  3. Jordan Patent Office Official Publications.
  4. International Search Reports and Patent Analyses (if available).
  5. Pharmaceutical patent law and practice in the Middle East region.

Note: Precise claim language, official patent documents, and legal filings are necessary for exhaustive analysis.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.